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Abstract 
Background: Soil-transmitted helminths (STH) are intestinal parasites estimated to infect over 1.5 billion people. Cur-
rent treatment programmes are aimed at morbidity control through school-based deworming programmes (target-
ing school-aged children, SAC) and treating women of reproductive age (WRA), as these two groups are believed to 
record the highest morbidity. More recently, however, the potential for interrupting transmission by treating entire 
communities has been receiving greater emphasis and the feasibility of such programmes are now under investiga-
tion in randomised clinical trials through the Bill & Melinda Gates Foundation funded DeWorm3 studies. Helminth 
parasites are known to be highly aggregated within human populations, with a small minority of individuals harbour-
ing most worms. Empirical evidence from the TUMIKIA project in Kenya suggests that aggregation may increase 
significantly after anthelminthic treatment.
Methods: A stochastic, age-structured, individual-based simulation model of parasite transmission is employed to 
better understand the factors that might induce this pattern. A simple probabilistic model based on compounded 
negative binomial distributions caused by age-dependencies in both treatment coverage and exposure to infection is 
also employed to further this understanding.
Results: Both approaches confirm helminth aggregation is likely to increase post-mass drug administration as 
measured by a decrease in the value of the negative binomial aggregation parameter, k. Simple analytical models of 
distribution compounding describe the observed patterns well.
Conclusions: The helminth aggregation that was observed in the field was replicated with our stochastic individual-
based model. Further work is required to generalise the probabilistic model to take account of the respective sensitivi-
ties of different diagnostics on the presence or absence of infection.
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Background
The soil-transmitted helminths (STH) are a group of 
intestinal parasites comprising Ascaris lumbricoides 
(roundworm), Trichuris trichiura (whipworm), and Neca-
tor americanus and Ancylostoma duodenale (the hook-
worms). STH are thought to induce the largest morbidity 
burden of all neglected tropical diseases (NTDs) [1], with 
chronic medium- to high-intensity infections associated 
with growth retardation and intellectual impairment in 
children, and anaemia. There are an estimated 1.5 billion 
individuals infected with at least one intestinal nema-
tode globally, cumulatively resulting in over five million 
disability-adjusted life years (DALYs) [2]. The great-
est burden of STH infection falls upon those of lowest 
socioeconomic status in Southeast Asia and sub-Saharan 
Africa [3]. The most common anthelmintic drugs in use 
against STH are albendazole and mebendazole. Both are 
known to have few side effects [4, 5] generally high effi-
cacy [6], and are currently donated for global use in de-
worming programmes by GlaxoSmithKline and Johnson 
& Johnson, respectively.
The World Health Organisation (WHO) STH treat-
ment guidelines currently target morbidity control, pri-
marily through repeated, school-based de-worming 
programmes and aim to treat women of reproductive 
age (WRA) [7]. However, finding and treating WRA can 
be challenging [8]. More recently, however, a debate 
has started around the possibility of eliminating trans-
mission, in addition to morbidity control, by expanding 
treatment across a broad class of age groups including, 
crucially, the adult population. This shift in focus was in 
part triggered by the London Declaration in 2012 which 
brought attention to the control of NTD morbidity by 
2020, and possible eradication of transmission of certain 
infections in some settings [9].
Previously published results have shown that interrup-
tion of transmission is unlikely to be achieved when only 
treating school-aged children (SAC) and WRA, since the 
untreated adult population will continue to contribute to 
the reservoir of infectious material thus causing reinfec-
tion amongst SAC [10–13]. This is especially the case for 
hookworm, where the majority of worms are harboured 
by adults [13], but it also applies to a lesser extent for 
the other prevalent STH species A. lumbricoides and T. 
trichiura [10]. It is important to note that even though 
WRA suffer more from morbidity than the adult male 
population, untreated adult males may harbour signifi-
cant worm populations. Therefore, just treating SAC 
and WRA is unlikely to result in the interruption of 
transmission.
Successfully interrupting transmission would stop the 
need for long-term MDA in areas of endemic infection. 
Faced with the prospect of a never-ending dependence on 
MDA, countries are starting to consider expanding de-
worming efforts beyond current school-based approaches 
[14–17]. As a result, greater emphasis has been placed 
upon implementing community-wide mass drug admin-
istration (MDA) de-worming programmes. The impact 
of successive rounds of MDA on STH prevalence is the 
primary focus of the Bill & Melinda Gates Foundation 
funded DeWorm3 project in India, Malawi and Benin 
[18]. This project is investigating whether a community-
wide MDA-only approach to STH treatment, would be 
sufficient to reach a prevalence threshold below which 
helminth parasite populations cannot sustain transmis-
sion, thus leading to transmission elimination [19–21]. 
All STH species reproduce sexually within a human host 
to produce fertile eggs. When the mean worm burden in 
a population falls to very low levels, the likelihood of both 
a male and female worm residing within a single human 
host becomes very small. A “breakpoint” is reached when 
the worm population can no longer sustain reproduction, 
resulting in the interruption of transmission even in the 
absence of further treatment [20, 21].
Helminth parasites are highly aggregated within human 
populations, with a small minority of individuals har-
bouring the majority of worms [22–27]. This “clump-
ing” increases the likelihood that parasites successfully 
locate members of the opposite sex within a human host. 
Hence, the breakpoint in infection is much lower when 
parasites are aggregated as compared to randomly dis-
tributed throughout the host population. The aggrega-
tion parameter of the negative binomial distribution, k, 
inversely measures the extent of “clumping” or worm 
aggregation present in the human host population. The 
smaller the value of k, the greater the extent of aggre-
gation [13]. As MDA coverage intensifies in endemic 
regions, it becomes more important to understand how 
the increased treatment pressure impacts the pattern of 
parasite aggregation, and whether any changes can help 
provide information to assist in improving the design of 
community-based MDA programmes. In this study, we 
investigate the impact of MDA on worm aggregation 
via observed patterns in communities experiencing high 
MDA coverage; through the predictions of probability 
models of the impact of MDA; and through individual-
based stochastic simulations of parasite transmission and 
MDA impact under different patterns of individual com-
pliance to multiple rounds of treatment.
Previous work has suggested that the probability with 
which repeated rounds of MDA will successfully result 
in transmission elimination is highly dependent on both 
treatment coverage, i.e. the proportion of individuals 
taking medication at any one round of treatment [28], 
and treatment compliance, i.e. the proportion of MDA 
rounds that each individual takes treatment [29, 30]. Past 
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research has shown that the impact of a community-
based MDA programme is greatly influenced by the spe-
cific pattern of non-compliance [30]. At one end of the 
spectrum it could be random, where all individuals have 
an equal chance of being treated at each round. At the 
other extreme is systematic non-compliance whereby 
the same individuals do not take treatment at any round 
of MDA. An intermediary pattern is semi-systematic in 
which each individual is assigned a lifelong probability 
of taking treatment at each round [30, 31]. Each of these 
non-compliance patterns may affect observed parasite 
aggregation patterns. Therefore, the analyses reported 
in this paper also examine the impact of different MDA 
compliance scenarios on the aggregation of parasites 
within the human host.
The overall aim of this study is to determine whether 
repeated, community-wide anthelminthic treatment has 
an impact on the degree of parasite aggregation and, if 
so, whether this impact can be predicted as a function 
of MDA coverage and compliance. We also discuss the 
policy implications of increased parasite aggregation 
post-MDA, as the prevalence of infection declines to low 
levels.
Methods
Empirical data derived from a large-scale field epide-
miological study provided the stimulus for this research 
on parasite aggregation. The TUMIKIA project was a 
cluster-randomised, controlled trial conducted in Kwale 
County, Kenya, from March 2015 to May 2017. The Kwale 
County has received MDA to control lymphatic filariasis, 
which is also effective for the control of STH. Annual 
school-based MDA has been provided to this county 
three years before the start of the trial. The trial com-
pared the impact on STH infection of annual and bian-
nual MDA, versus annual mass anthelmintic treatment 
of children (2–14 years-old) [32, 33]. Recently, Truscott 
et al. [34] investigated the heterogeneity in transmission 
parameters from the TUMIKIA trial. Data obtained from 
the TUMIKIA study provided evidence of changes in the 
negative binomial aggregation parameter k, under inten-
sive MDA. Clusters with a low prevalence were found to 
have a higher degree of parasite aggregation [34] (Fig. 1). 
In this study, we further investigate the changes in para-
site aggregation. Since observations from the TUMIKIA 
study related to N. americanus, this will be the parasite 
of reference in this paper. However, results relating to A. 
lumbricoides will also be summarised, with further detail 
and figures provided in Additional file 1: Figures S1–S5.
We employ an event-driven, individual-based stochas-
tic model of helminth transmission [30], building on 
a model framework originally described by Anderson 
& May [35] and Anderson & Medley [36]. The model 
includes age-dependent infection rates, density-depend-
ent worm fecundity, parasite sexual reproduction which 
is assumed to be polygamous, and a negative binomial 
distribution of parasites per person [37]. The latter is 
created by assigning an exposure risk factor to indi-
viduals drawn from a gamma distribution for a specific 
age-grouping (the compounding of Poisson distribu-
tions where the means are drawn from a gamma distri-
bution [38]). It is the dynamics of sexual reproduction 
for dioecious species which results in the occurrence of 
three possible equilibria in the deterministic dynamical 
system; a stable endemic state, and parasite extinction, 
separated by an unstable “breakpoint” in transmission 
below which the attractor is extinction [27]. We denote 
this as a prevalence threshold below which the parasite 
population cannot sustain transmission. Once this state 
is reached, there is no need for further MDA assuming 
an absence of infective individuals migrating to the area 
who could re-populate the reservoir of infection. In a sto-
chastic world, the deterministic concept of a breakpoint 
needs expansion to a small area around the deterministic 
breakpoint where the system, due to chance events, may 
move to either stable equilibrium. The individual-based, 
stochastic modelling of events via numerical studies 
allows for the explicit inclusion of heterogeneity between 
individuals, such as in treatment compliance and expo-
sure to infection, as well as probabilistic forecasts of the 
likely impact of different MDA programmes in a vari-
ety of transmission settings (e.g. low, medium and high 
transmission settings as defined by the value of the basic 
reproductive number,  R0).
Fig. 1 Observed relationship between measured prevalence and 
aggregation, k, from TUMIKIA project. Originally published in Truscott 
et al. [34]. The crosses in represent the prevalence values of 10% and 
60%. In the TUMIKIA study, the lowest k-values were found in low 
prevalence clusters (< 10%) and the highest k-values were found in 
clusters with a prevalence of approximately 60%
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The parameter values employed in the individual-based, 
stochastic simulation model for N. americanus and A. lum-
bricoides are presented in Table 1. Each stochastic model-
based simulation comprised 1000 villages, each containing 
1000 individuals. All villages underwent five rounds of 
annual, community-wide MDA, with coverage levels for N. 
americanus set at 85% for both pre-school-aged children 
(pre-SAC) and SAC, and 75% for adults, whilst for A. lum-
bricoides coverage was 75% for pre-SAC and SAC, and 30% 
for adults. These coverage levels were selected to ensure 
that a proportion of simulations achieved elimination and 
a proportion did not, such that the validity of the predic-
tions of the simple analytical model could be compared 
with those of the more complex individual stochastic 
model in both scenarios. Simulations were run for 10 years 
pre-treatment and 30 years post-treatment to ensure STH 
prevalence had reached equilibrium both before and after 
anthelmintic treatment was provided.
At each time point, the effective negative binomial 
aggregation parameter is calculated by finding the maxi-
mum likelihood estimate kˆ from the distribution of worm 
burdens amongst hosts [39]. These estimates are sub-
sequently presented as line graphs showing how worm 
aggregation changes over time. STH prevalence is also 
calculated for each village at each time points.
The impact of treatment on parasite aggregation can also 
be expressed in a simplified probability model from which 
some key analytical results can be derived. In a homogenous 
population, worm burdens among hosts are precisely nega-
tive binomial, with a fixed k value within our simulation. 
However, once heterogeneities are introduced, such as age 
structure and differing uptake of MDA within the popula-
tion, this is no longer the case. Worm burden distributions 
after MDA or across wide age ranges with differing expo-
sure intensities can be described by a compound distribu-
tion, in which the underlying negative binomial distribution 
is compounded by the probability distribution associated 
with the given source of heterogeneity. Using this approach, 
we can approximate the impact of these mechanisms on 
aggregation by calculating the changes to both the mean and 
variance of the worm burden among hosts that they influ-
ence. For a negative binomial distribution, the relationship 
between the aggregation parameter k, the mean µ and the 
variance σ2 is given by
Under the effect of heterogeneity, the new values of 
mean worm burden and variance can be used to calculate 
an effective aggregation parameter, k′, under the assump-
tion that the worm distribution is still approximately 
negative binomial.
In the case of MDA with imperfect coverage, a round of 
treatment splits the target population into two sub-pop-
ulations: a treated group with reduced worm burden and 
an untreated group whose worm burden is assumed to be 
unchanged. Using the technique described by Anderson 
& May [27], for a round of MDA, with coverage c and 
efficacy ef, applied to a homogeneous host sub-popula-
tion with mean worm burden m and aggregation k, the 
approximate aggregation post-treatment is
By extending this approach, we can also incorporate 
the heterogeneity induced by age-dependent exposure to 
infection. For further information, please see Additional 
file 2: Text S1.
If we consider the impact of treatment across a range 
of ages where there is a significant difference in exposure 
to infection, a further level of variability is introduced 
k =
µ2
σ 2 − µ
.
(1)k ′ ≃ k
(1− ef c)
2
(k + 1)e2f c(1− c)+ (1− ef c)
2
.
Table 1 Parameters used for the individual-based, stochastic simulation models
Model parameter description A. lumbricoides N. americanus
Transmission rate,  R0 2.12 2.2
Aggregation of worms within human hosts, k 0.15 0.35 [25]
Relative exposure to infection and contribution to infective reservoir (assuming no differ-
ences between males and females)
0–2 years-old: 0.22 0–2 years-old: 0.03
2–5 years-old: 1.88 2–5 years-old: 0.09
5–15 years-old: 1 5–15 years-old: 1
15+ years-old: 0.53 15+ years-old: 2.5 [49]
Average worm life expectancy (years) (assuming an exponential distribution) 1 [50] 2 [51]
Female worm fecundity, γ 0.07 [37] 0.02 (assuming expo-
nential saturation) 
[52]
Infectious reservoir decay rate (mean) 2 months [35] 12 days [51]
Drug efficacy 0.99 [40] 0.948 [40]
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into the calculation. If we construct N age categories, the 
probability of sampling (randomly) from the ith is
where the value of  m0 and c are functions of the age-
group i. The new variance of worm burden now becomes
This can be expressed in terms of the previous simpler 
expression for the variance
Since coverage levels and mean worm burden are both 
functions of age group, this expression cannot be evalu-
ated in closed form.
The expected k values, mean worm burdens and vari-
ance in worm counts immediately post-treatment are 
calculated from the pre-treatment data obtained from 
the simulations. These expected post-treatment values 
are then compared to those observed from the simula-
tions to determine the validity of the simple analytical 
predictions. Scatterplots are used to visually portray the 
comparisons.
Results
Predictions based on the stochastic simulations
At equilibrium, N. americanus prevalence was approxi-
mately 65% in all villages for all compliance scenar-
ios. After cessation of treatment, village prevalence 
either recovered to pre-treatment equilibrium levels 
or decreased to zero, depending on whether the break-
point in transmission was crossed. The proportion of 
villages achieving N. americanus elimination was 89.4% 
under random non-compliance, 41.7% for semi-system-
atic compliance and 0% for fully-systematic compliance 
(Fig.  2a–c). For A. lumbricoides the equivalent propor-
tions were 75.4%, 65.6% and 42.8%, respectively (Addi-
tional file 1: Figure S1a–c). These results clearly illustrate 
the importance of individual compliance as a key deter-
minant of MDA impact. This effect is not widely appreci-
ated by those who track MDA coverage as reported on a 
country to country basis to WHO. In the WHO compila-
tions of year by year progress in MDA, coverage is docu-
mented but not compliance.
Under random non-compliance, k decreased sharply 
(reflecting increased parasite aggregation) to between 
0.102 and 0.160 directly following the first round of treat-
ment. Similar patterns were also observed in both the 
p(i) =
#people in ithage group
Total population
Var[w]′ = EiEm[Varw[w(m)]]]+Ei[Varm[Ew[w(m)]]]+Vari[Em[Ew[w(m)]]]
Var[w]
′ = Ei[Var[w](m0(i), c(i))]
+ Vari[m¯(m0(i), c(i))]
fully-systematic and semi-systematic non-compliance 
scenarios (range: 0.100–0.160 and 0.100–0.151, respec-
tively). In all scenarios, k became successively smaller 
after each round of treatment, with the recovery in k 
immediately post-treatment consistently lower than at 
each previous round. Furthermore, the range in k values 
recorded in the stochastic simulations increased slightly 
after each successive round of treatment. In villages 
where elimination of transmission was successful (the 
“breakpoint” in transmission was crossed), the preva-
lence declined to zero and k concomitantly decayed to 
a value of zero. On average, this took 12 years post-ces-
sation of treatment for random non-compliance (range: 
3.0–21.0 years) and 14.5 years for semi-systematic (range: 
6.5–21.0  years). No simulations in the fully-systematic 
non-compliance scenario resulted in elimination, hence 
no k values reached zero.
For A. lumbricoides, the duration of time for k to 
reach zero post-treatment was 6.5  years for random 
non-compliance (range: 0.5–20.0  years), 7.0  years for 
semi-systematic compliance (range: 1.5–19.5  years), 
and 8 years for fully-systematic non-compliance (range: 
3–21.0  years). In those villages which failed to reach 
elimination and suffered bounce-back in infection to 
pre-treatment equilibrium levels, k was observed to 
also return to its pre-treatment value. On average, this 
bounce-back took approximately 6 years post-cessation 
of treatment for both N. americanus (Fig.  2d–f ) and 
A. lumbricoides (Additional file  1: Figure S1d–f ). No 
significant difference was observed between different 
compliance patterns with regards to the duration of 
time required for k to return to pre-treatment equilib-
rium levels.
The short- and long-term impact of treatment can 
also be observed in the age-prevalence surface plots (the 
dimensions of age and time). At equilibrium, the preva-
lence of hookworm infection was higher amongst adults 
than pre-SAC and SAC. Treatment resulted in a decrease 
in prevalence amongst all age groups, with the greatest 
relative decrease observed in adults. In villages which 
did not reach elimination and bounced-back to the pre-
treatment equilibrium, the post-treatment age-preva-
lence profiles were near-identical to pre-treatment levels 
(Fig. 3, Additional file 1: Figure S2).
The proportion of individuals who still harbour worms 
after MDA showed differences between the compliance 
patterns types (Additional file  1: Figure S3). At round 
five, the proportion of individuals who harbour at least 
one worm were 5.1% (0.8–12.5%), 7.8% (2.9–16.6%) and 
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16.1% (10.4–24.1%) for random, semi-systematic and 
fully-systematic non-compliance (Additional file  1: Fig-
ure S3). The proportion of individuals who harbour both 
male and female worms reduced on average to 1.2% 
(0–4.5%) with random compliance (Fig.  4). With fully-
systematic non-compliance, the proportion of individu-
als with both male and female worms remained high 
even after five rounds of MDA (8.4%, 5.0–13.4%) allowing 
transmission to be sustained. Similar results were found 
for A. lumbricoides (Additional file 1: Figures S3, S4).
Simple theory compared with the outcomes predicted 
by the complex stochastic simulations
The impact of MDA on the degree of aggregation was 
found to be described well by the simple probability 
model of compounding distributions created by het-
erogeneities within the host population due to either 
compliance to treatment or exposure to infection. For 
N. americanus, a high degree of agreement was seen 
between the mean worm burden and k values observed 
from the stochastic simulations immediately post-treat-
ment and those expected under the simple probability 
model defined by the equations given in Additional 
file 2: Text S1. Strong agreement between observed and 
expected results was identified for A. lumbricoides, with 
the variance in worm count post-treatment showing a 
much stronger agreement between models than was 
found for N. americanus (Fig. 5; Additional file 1: Figure 
S5).
Discussion
We have shown that the aggregation parameter k 
decreases immediately after each round of treatment 
reflecting increased parasite aggregation within the 
human host population. Furthermore, this decrease can 
be accurately predicted using a simple probability model 
which incorporates heterogeneities within human host 
populations created by either age-dependencies in worm 
burden (i.e. age-dependent exposure to infection) and/
or variation in treatment coverage by age. In the long-
term over multiple rounds of MDA, the decline in the 
value of k follows the decline in prevalence within any 
given village. Our results show that the A. lumbricoides 
simulations are more likely to achieve interruption of 
Fig. 2 Prevalence of Necantor americanus over time (a–c) and aggregation (parameter k) over time (d–f), in this plot we show 500 out of 1000 
simulated villages. a and d: Random non-compliance; b and e: Semi-systematic non-compliance; c and f: Fully-systematic non-compliance
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transmission for all three compliance types. This is likely 
to be the result of higher coverage in the SAC-population 
which have typically the highest A. lumbricoides worm 
burden. Whilst for hookworm the opposite is noticed. 
Moreover, the egg reduction rate is slightly higher for A. 
lumbricoides [40].
The simple model requires data describing the num-
ber of worms within each individual host both pre- and 
post-treatment. Worm expulsion post treatment is both 
time- and resource-intensive, by comparison with col-
lecting data on egg counts via stool examination (typi-
cally through Kato-Katz, KK). Worm expulsion data can 
be unreliable since stool samples need to be collected 
for at least 6 consecutive days to collect at least 80% of 
A. lumbricoides worms post-treatment [41]. Given that 
hookworms are much smaller than A. lumbricoides, 
worm counts are considered even less precise as many 
worms are likely to be missed in the collected stool. Since 
worm expulsions are performed by giving individuals 
chemotherapeutic treatment, the collection of empirical 
“pre-treatment” worm counts is often not possible in cur-
rent government run deworming treatment programmes. 
We can extract information on worm burden at any time 
point from the individual-based stochastic simulations 
models, but such data are difficult to obtain in ongo-
ing field epidemiological studies. One potential solution 
(although by no means a perfect one) could be to com-
pare post-treatment worm expulsion data with pre-treat-
ment KK intensity data for the same individuals. Whilst 
this would not be “worm expulsions” at both time points 
and the two measures would not necessarily be directly 
comparable, this approach may be of help given good 
data on the relationship between worm burdens and egg 
counts.
Egg count data, collected at both pre- and post-treat-
ment, can be used as a proxy for worm count data. How-
ever, microscopic diagnostic tools, such as KK, have 
a reduced sensitivity at low intensities of infections. 
Fig. 3 Age-prevalence over time in which elimination of Necator 
americanus infection was not achieved before mass drug 
administration was implemented (a) and post-MDA (b). Age groups 
(years): 1, 0–5; 2, 6–10; 3, 11–15; 4, 16–30; 5, 31–50; 6, 51+
Fig. 4 The proportion of individuals who harbour both male and female worms and produce fertile eggs (grey shaded color) and the proportion 
of individuals who harbour either only male or only females worms and produce no eggs (orange shaded color) for random compliance (a), 
semi-systematic compliance (b) and systematic compliance (c)
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Nikolay et  al. [42] showed that whilst the sensitivity of 
double-slide KK (the most commonly used microscopic 
diagnostic tool) was acceptable for the three major STH 
species in high-intensity of infection areas (sensitivity of 
74–95%), it was much less reliable in areas of low inten-
sity (sensitivity of 53–80%), with the lowest values being 
for hookworm and A. lumbricoides. Therefore, these 
diagnostic tools are less suitable for populations that are 
close to reaching the breakpoint in transmission. The 
increasing use of MDA combined with the ongoing push 
for STH elimination will likely result in greater pres-
sure on the use of more sensitive diagnostics to detect 
infection at lower prevalence and intensity. To this end, 
there has been increased interest in recent years in the 
potential use of quantitative polymerase chain reaction 
(qPCR) assays as a diagnostic tool for STH infections [43, 
44]. This technique has greater sensitivity than KK espe-
cially when the prevalence and intensity of infection are 
both low [20, 43, 44]. The use of improved diagnostics 
with increased sensitivity will be very beneficial in areas 
approaching the breakpoint in transmission to ascertain 
if transmission has ceased. However, the increased costs 
of qPCR by comparison with KK may be a deterrent in 
low resource settings.
Calculating k values was found to be difficult for some 
villages in both the random and semi-systematic non-
compliance simulations post-cessation of treatment due 
to very low average worm burdens such that very few 
individuals were infected. When all individuals within a 
village have either zero or one worm, as was the case in 
the villages for which k could not be estimated, the nega-
tive binomial distribution no longer describes the worm 
burden distribution and a Bernoulli distribution is a more 
appropriate probability model. In these circumstances, 
no negative binomial aggregation parameter could be 
derived and the maximum likelihood analysis was forced 
to select whichever value was set as the upper limit for k 
as the best fit (here, k = 0.5) in the estimation process. A 
fuller explanation is presented in Additional file  2: Text 
S1.
Aggregation of macroparasites within the human hosts 
is a commonly observed epidemiological feature. The 
degree of overdispersion can depend on the parasite spe-
cies, host age and gender, and the transmission setting. 
For example, children are often predisposed to heavy 
A. lumbricoides infection. Predisposition to hookworm 
infection is also observed, but the factors that are linked 
to predisposition are not well understood at present [45]. 
It may be some combination of genetic, behavioural and 
environmental factors.
Understanding compliance within a study through 
the collection of individual-based, longitudinal treat-
ment data is of the upmost importance. The probabil-
ity of successfully eliminating N. americanus infection 
within our simulations with a fixed level of coverage 
was highly dependent on the pattern of compliance 
assumed, ranging from almost 90% with random com-
pliance to 0% under systematic non-compliance. 
Therefore, it is crucial to the success of a deworming 
campaign aimed at breaking transmission that all indi-
viduals within a village are treated and that no indi-
viduals are systematically missed. This can occur when 
households are too remote, individuals persistently 
refuse treatment or if individuals are consistently not at 
home when health care workers are visiting. Knowledge 
of the factors that influence persistent non-compliance 
Fig. 5 Results from analytical approach for predicting change in aggregation after treatment under semi-systematic non-compliance. a 
Comparison of mean worm burden observed from the stochastic model immediately post-treatment and that expected from the simple 
probability model. b Comparison of k observed from the stochastic model immediately post-treatment and that expected from the simple 
probability model. Note: for a, the grey line represents the equation x = y (perfect agreement)
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can help in the design and implementation of parasite 
control programmes.
Knowledge regarding the extent of compliance within 
a population targeted for treatment can contribute 
towards an understanding of whether or not to stop 
randomised STH control trials, such as DeWorm3, 
earlier than originally planned [18, 21]. If compliance 
is consistently poor there is little point in continuing 
treatment, monitoring and evaluation since transmis-
sion elimination is unlikely to occur.
Anthelmintic resistance is a significant problem in 
livestock farming and is increasingly reported amongst 
by the veterinary profession. It is important to note 
that drug pressure in livestock is much higher, in part 
as a consequence of livestock being treated five times 
a year and hence parasites have a high and repeated 
exposure to the drug selective pressure. Nonetheless, 
the risk of developing drug resistance in human STH 
is important to monitor when the goal is shifting from 
morbidity control towards interruption of transmis-
sion. This is especially true for species with a subopti-
mal response to the drugs, for example the response of 
T. trichiura to albendazole and mebendazole. With the 
shift towards interruption of transmission, drug pres-
sure within a population increases substantially and 
concomitantly selection pressure on the parasite pop-
ulation. Even though there is widespread agreement 
regarding the importance of monitoring drug resist-
ance, reliable studies investigating this challenge are 
very few at present. Microscopic diagnostic tools and 
qPCR alone are not sufficient to identify drug resist-
ance, other methods such as population genetics are 
required. Worm DNA needs to be isolated from expul-
sion studies and the beta-tubulin gene (where resist-
ance has been reported before) needs to be sequenced. 
One example of recent progress is the STARWORM 
project which aims to identify standardized methods 
to monitor drug resistance [46]. During the DeWorm3 
trial drug resistance is being closely monitored 
and samples are being stored to investigate resist-
ance mutations in future molecular epidemiological 
analyses. If drug resistance appears to develop in the 
DeWorm3 study sites, it will be important to under-
stand why this is the case and monitoring changes in 
aggregation patterns can support the detection of drug 
resistance [18].
The effects of migration of infectious individuals on 
the likelihood of interrupting transmission are poorly 
understood at present for helminth control. However, 
much recent infectious disease research is focused on 
this issue employing simple or complex models of spa-
tial structure and human and animal movement. In this 
study, we assumed that villages behave as independent 
units with no immigration or emigration of infectious 
individuals. Recent molecular epidemiological analy-
ses performed by Easton et al. [47], showed that for A. 
lumbricoides infection in Bungoma (Kenya), the village 
is the most appropriate epidemiological unit for study, 
since molecular epidemiological analyses revealed that 
the vast majority of transmission takes place between 
village members. If there is a lot of migration between 
villages, the risk of transmission from one village to 
another increases. However, this risk will depend on a 
number of factors, including the prevalence of infection 
and its heterogeneity between villages, heterogeneity 
in treatment coverage and compliance between vil-
lages, the age-group that moves most between villages 
and also the age-intensity profiles. For example, if there 
is a high prevalence of A. lumbricoides in one village, 
there is a low risk of transmission between villages as a 
consequence of migration if adults are the major migra-
tory group. Whilst for hookworm the opposite is true 
and reaching a breakpoint will be difficult if much adult 
movement takes place [48]. Coverage and compliance 
on the village-level or household-level are obviously 
of high importance. If for example, a few households 
refuse to take the treatments offered in MDA rounds, 
they may maintain a local reservoir of infection within 
a village, which can complicate reaching the trans-
mission breakpoint. How serious this complication is, 
depends on the contact of other village members with 
non-compliant households. Data currently being col-
lected during the DeWorm3 trials will be very benefi-
cial in parameterizing spatially structured models and 
in refining programmes that aim to interrupt transmis-
sion of STH on large spatial scales.
In future research, it is important to adapt the meth-
ods outlined in this paper to allow for the use of egg 
counts (eggs per gram of faeces; EPG) as opposed to 
the worm counts (which require high resource alloca-
tion to ensure accuracy). Worm expulsion studies are 
considerably more time- and resource-intensive than 
obtaining faecal egg counts via Kato-Katz. Adapting 
the simple model, such that EPG data can be utilised, 
will allow for the methodology to be used more widely 
within STH studies.
Conclusions
We have shown how the increased aggregation in STH 
infection post-treatment observed in empirical studies 
can be predicted using a simple probability model based 
on compounding distributions arising from hetero-
geneities due to age-dependent exposure to infection 
and/or different patterns of MDA uptake by individ-
ual people. Ongoing studies under the TUMIKIA and 
D3Worm3 projects will provide further information 
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on patterns of individual compliance. For hookworm, 
infection individual compliance is thought to be the 
major cause of the observed patterns of increasing 
parasite aggregation with increasing numbers of MDA 
rounds in given communities. Increased aggregation 
of worms after many rounds of chemotherapy suggests 
that once the prevalence of infection has reached low 
levels an approach to target and treat those predisposed 
to infection and non-compliant to treatment may be 
highly beneficial.
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